Stoke Therapeutics Inc (STOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 155,659 | 84,220 | 83,394 | 101,547 | 274,892 |
| Marketable Securities | 187,886 | 200,450 | 164,916 | 146,236 | 82,507 |
| Receivables | 6,141 | 7,905 | 10,837 | 1,622 | 606 |
| Other current assets | 6,880 | 4,389 | 5,543 | 6,871 | 5,037 |
| TOTAL | $366,681 | $305,700 | $272,437 | $269,970 | $375,736 |
| Non-Current Assets | |||||
| PPE Net | 3,395 | 3,146 | 3,083 | 3,343 | 3,611 |
| Investments And Advances | 67,481 | 106,260 | 80,315 | 107,256 | 22,989 |
| Other Non-Current Assets | 5,720 | 3,328 | 4,429 | 3,939 | 4,552 |
| TOTAL | $76,596 | $112,734 | $87,827 | $114,538 | $31,152 |
| Total Assets | $443,277 | $418,434 | $360,264 | $384,508 | $406,888 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,839 | 4,939 | 5,871 | 4,313 | 2,186 |
| Accrued Expenses | 23,901 | 41,035 | 30,093 | 25,616 | 24,335 |
| TOTAL | $40,806 | $57,875 | $41,727 | $38,678 | $44,685 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 10,066 | 11,901 | 5,763 | 8,749 | 18,164 |
| Other Non-Current Liabilities | 991 | 1,141 | 1,874 | 1,255 | 1,874 |
| TOTAL | $7,594 | $8,102 | $10,432 | $10,887 | $12,129 |
| Total Liabilities | $48,400 | $65,977 | $52,159 | $49,565 | $56,814 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62,282 | 59,151 | 57,117 | 54,797 | 54,597 |
| Common Shares | 6 | 5 | 5 | 5 | 5 |
| Retained earnings | -547,718 | -497,715 | -439,781 | -401,434 | -377,951 |
| Other shareholders' equity | -115 | 543 | 446 | 96 | -104 |
| TOTAL | $394,877 | $352,457 | $308,105 | $334,943 | $350,074 |
| Total Liabilities And Equity | $443,277 | $418,434 | $360,264 | $384,508 | $406,888 |